In oral tumour cells, secreted LOXL2 oxidises lysine residues in platelet-derived growth factor receptor beta (PDGFRβ) on stromal fibroblasts, enhancing platelet-derived growth factor (PDGF-AB) signalling and promoting stromal fibroblast proliferation via ERK activation [102]. The gene discussed is LOXL2; the disease is neoplasm.